This Monday seems to be a lucrative one for investors in biopharmaceutical companies. It seems like everybody has some good news to report, whether that be optimistic trial data or a successful merger or acquisition. Flexion Therapeutics (NASDAQ:FLXN) is joining the pack of medicine plays that’s boasting bullish news today. An incoming merger between Flexion and…

No doubt, a strong portfolio typically includes stocks with robust fundamentals and solid track records. In a bull market, these investments provide healthy returns and protect against capital erosion. However, we should not overlook the benefits of owning penny stocks, either. The get-rich-quick angle with these picks is a real possibility. That’s why they continue…